Predictions
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.91
13.08.22
13.08.22
€1.00
13.08.23
13.08.23
-12.70%
23.08.22
23.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
US Physical Therapy Inc.
Start price
Target price
Perf. (%)
€122.00
26.07.22
26.07.22
-
26.07.23
26.07.23
-9.84%
26.07.23
26.07.23
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€235.25
13.07.22
13.07.22
€239.00
13.07.23
13.07.23
-1.59%
13.07.23
13.07.23
Fluidigm Corp.
Start price
Target price
Perf. (%)
€1.68
27.06.22
27.06.22
-
27.06.23
27.06.23
-10.79%
24.04.23
24.04.23
Probably not worthwhile Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.77
10.06.22
10.06.22
€0.20
10.06.23
10.06.23
24.58%
26.06.22
26.06.22
Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
Bovie Medical Corp
Start price
Target price
Perf. (%)
€5.90
28.05.22
28.05.22
-
28.05.23
28.05.23
-55.93%
24.04.23
24.04.23
Risky Investment
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€471.15
17.05.22
17.05.22
-
17.05.23
17.05.23
-6.19%
17.05.23
17.05.23
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.42
16.05.22
16.05.22
-
16.05.25
16.05.25
-53.44%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.42
15.05.22
15.05.22
-
15.05.23
15.05.23
81.90%
24.04.23
24.04.23
Risky Investment
Growths slower than the competition
Teladoc Health Inc
Start price
Target price
Perf. (%)
€36.83
03.05.22
03.05.22
€30.00
03.05.23
03.05.23
-38.60%
11.03.23
11.03.23
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.77
28.04.22
28.04.22
€25.00
28.04.23
28.04.23
19.70%
03.05.22
03.05.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€7.59
01.04.22
01.04.22
€12.50
01.04.23
01.04.23
-76.56%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year
Vyant Bio Inc.
Start price
Target price
Perf. (%)
€8.50
30.03.22
30.03.22
-
30.03.23
30.03.23
-24.12%
31.03.22
31.03.22
Risky Investment
Bovie Medical Corp
Start price
Target price
Perf. (%)
€6.45
20.03.22
20.03.22
-
20.03.23
20.03.23
-8.53%
28.05.22
28.05.22
Risky Investment
Teladoc Health Inc
Start price
Target price
Perf. (%)
€54.20
16.03.22
16.03.22
€65.00
16.03.23
16.03.23
-43.24%
28.04.22
28.04.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc
Start price
Target price
Perf. (%)
€46.58
14.03.22
14.03.22
€35.00
14.03.23
14.03.23
16.36%
16.03.22
16.03.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc
Start price
Target price
Perf. (%)
€64.00
30.01.22
30.01.22
€65.00
30.01.23
30.01.23
-27.22%
14.03.22
14.03.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€246.90
30.01.22
30.01.22
€270.00
30.01.23
30.01.23
-9.98%
31.01.23
31.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Meridian Bioscience Inc.
Start price
Target price
Perf. (%)
€19.00
28.01.22
28.01.22
€20.00
28.01.23
28.01.23
62.63%
29.01.23
29.01.23
Could be worthwhile Investment >10% per year